Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133668) titled 'Personalized and precise treatment for Helicobacter pylori' on Sept. 30.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Peking Union Medical College Hospital
Condition:
helicobacter pylori infection
Intervention:
Patients who are not allergic to penicillin (Tegolafloxacin + Amoxicillin):None
Penicillin allergy and resistance to clarithromycin (Tegolafungin + Minocycline + Bismuth compound):None
Allergic to penicillin and sensitive to clarithromycin (Tigolastine + Clarithromycin):None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-10-08
Target...